NURS 6521: Advanced Pharmacology Assignment Resources<\/p>\n
Syllabus<\/p>\n
Resource List
\nThis page contains all of the resources for this course.<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 1
\nRequired Readings<\/p>\n
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 1, \u201cPrescriptive Authority\u201d (pp. 1\u20133)
\nChapter 2, \u201cRational Drug Selection and Prescription Writing\u201d (pp. 5\u20139)
\nChapter 3, \u201cPromoting Positive Outcomes of Drug Therapy\u201d (pp. 11\u201316)
\nChapter 4, \u201cPharmacokinetics, Pharmacodynamics, and Drug Interactions\u201d (pp. 17\u201340)
\nChapter 5, \u201cAdverse Drug Reactions and Medical Errors\u201d (pp. 41\u201349)
\nChapter 6, \u201cIndividual Variation in Drug Response\u201d (pp. 51\u201356)
\nAmerican Geriatrics Society 2019 Beers Criteria Update Expert Panel. (2019). American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674\u2013694. doi:10.1111\/jgs.15767 American Geriatrics Society 2019 Updated AGS Beers Criteria<\/p>\n
American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults by American Geriatrics Society, in Journal of the American Geriatrics Society, Vol. 67\/Issue 4. Copyright 2019 by Blackwell Publishing. Reprinted by permission of Blackwell Publishing via the Copyright Clearance Center.<\/p>\n
This article is an update to the Beers Criteria, which includes lists of potentially inappropriate medications to be avoided in older adults as well as newly added criteria that lists select drugs that should be avoided or have their dose adjusted based on the individual\u2019s kidney function and select drug-drug interactions documented to be associated with harms in older adults.<\/p>\n
Drug Enforcement Administration. (n.d.-a). Code of federal regulations. Retrieved February 1, 2019, from https:\/\/www.deadiversion.usdoj.gov\/21cfr\/cfr\/1300\/1300_01.htm<\/p>\n
This website outlines the code of federal regulations for prescription drugs.<\/p>\n
Drug Enforcement Administration. (n.d.-b). Mid-level practitioners authorization by state. Retrieved May 13, 2019 from http:\/\/www.deadiversion.usdoj.gov\/drugreg\/practioners\/index.html<\/p>\n
This website outlines the schedules for controlled substances, including prescriptive authority for each schedule.<\/p>\n
Drug Enforcement Administration. (2006). Practitioner\u2019s manual.<\/p>\n
Retrieved from http:\/\/www.deadiversion.usdoj.gov\/pubs\/manuals\/pract\/index.html<\/p>\n
This manual is a resource for practitioners who prescribe, dispense, and administer controlled substances. It provides information on general requirements, security issues, recordkeeping, prescription requirements, and addiction treatment programs.<\/p>\n
Drug Enforcement Administration. (n.d.-c). Registration. Retrieved February 1, 2019, from https:\/\/www.deadiversion.usdoj.gov\/drugreg\/index.html<\/p>\n
This website details key aspects of drug registration.<\/p>\n
Fowler, M. D. (2015). Guide to the code of ethics for nurses with interpretive statements: Development, interpretation, and application.<\/p>\n
Retrieved from This article is an update to the Beers Criteria, which includes lists of medications that may not be right for older people and should be avoided, as well as newly added criteria that list certain drugs that should be avoided or have their dose changed based on the person’s kidney function and certain drug-drug interactions that have been shown to cause harm in older people.<\/p>\n
The Drug Enforcement Agency (n.d.-a). The federal code of rules. Taken from https:\/\/www.deadiversion.usdoj.gov\/21cfr\/cfr\/1300\/1300 01.htm on February 1, 2019.<\/p>\n
On this website, you can read about the rules that the federal government has for prescription drugs.<\/p>\n
The Drug Enforcement Agency (n.d.-b). The state decides who can be a mid-level practitioner. Found at http:\/\/www.deadiversion.usdoj.gov\/drugreg\/practioners\/index.html on May 13, 2019.<\/p>\n
This website tells you about the schedules for controlled substances and gives you information about who can write prescriptions for each schedule.<\/p>\n
Practitioner’s manual, published by the Drug Enforcement Administration in 2006.<\/p>\n
Find out more at http:\/\/www.deadiversion.usdoj.gov\/pubs\/manuals\/pract\/index.html.<\/p>\n
This book is a guide for doctors, pharmacists, and nurses who prescribe, dispense, or give controlled substances. It tells you about general requirements, security issues, keeping records, prescription requirements, and treatment programs for addiction.<\/p>\n
The Drug Enforcement Agency (n.d.-c). Registration. Get this information from https:\/\/www.deadiversion.usdoj.gov\/drugreg\/index.html on February 1, 2019.<\/p>\n
This website has information about important parts of drug registration.<\/p>\n
Fowler, M. D. (2015). Guide to the code of ethics for nurses with statements about how it was made, how it should be interpreted, and how it should be used.<\/p>\n
Get this from<\/p>\n
https:\/\/eds-b-ebscohost-com.ezp.waldenulibrary.org\/eds\/ebookviewer\/ebook\/bmxlYmtfXzEwMjE3NjNfX0FO0?sid=8cf8b6d3-6338-4e98-8254-2cadb5d74ad5@sessionmgr103&vid=0&format=EB&rid=1<\/p>\n
This resource introduces the code of ethics for nurses and highlights critical aspects for ethical guideline development, interpretation, and application in practice.<\/p>\n
Institute for Safe Medication Practices. (2017). List of error-prone abbreviations, symbols, and dose designations. Retrieved from https:\/\/www.ismp.org\/recommendations\/error-prone-abbreviations-list<\/p>\n
This website provides a list of prescription-writing abbreviations that might lead to misinterpretation, as well as suggestions for preventing resulting errors.<\/p>\n
Ladd, E., & Hoyt, A. (2016). Shedding light on nurse practitioner prescribing. The Journal for Nurse Practitioners, 12(3), 166\u2013173. doi:10.1016\/j.nurpra.2015.09.17<\/p>\n
Note: You will access this article from the Walden Library databases.<\/p>\n
This article provides NPs with information regarding state-based laws for NP prescribing.<\/p>\n
Sabatino, J. A., Pruchnicki, M. C., Sevin, A. M., Barker, E., Green, C. G., & Porter, K. (2017). Improving prescribing practices: A pharmacist\u2010led educational intervention for nurse practitioner students. Journal of the American Association of Nurse Practitioners, 29(5), 248\u2013254. doi:10.1002\/2327-6924.12446<\/p>\n
Note: You will access this article from the Walden Library databases.<\/p>\n
The authors of this article assess the impact of a pharmacist\u2010led educational intervention on family nurse practitioner (FNP) students\u2019 prescribing skills, perception of preparedness to prescribe, and perception of pharmacist as collaborator.<\/p>\n
Required Media
\nIntroduction to Advanced Pharmacology<\/p>\n
Meet Dr. Terry Buttaro, associate professor of practice at Simmons School of Nursing and Health Sciences as she discusses the importance of pharmacology for the advanced practice nurse. (8m)<\/p>\n
Accessible player \u2013Downloads\u2013Download Video w\/CCDownload AudioDownload Transcript Introduction to Advanced Pharmacology<\/p>\n
ORDER NOW FOR AN ORIGINAL PAPER
\nNURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 2
\nRequired Readings<\/p>\n
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 34, \u201cReview of Hemodynamics\u201d (pp. 335\u2013340)
\nChapter 35, \u201cDiuretics\u201d (pp. 341\u2013349)
\nChapter 36, \u201cDrugs Acting on the Renin-Angiotensin-Aldosterone System\u201d (pp. 351\u2013362)
\nChapter 37, \u201cCalcium Channel Blockers\u201d (pp. 363\u2013369)
\nChapter 38, \u201cVasodilators\u201d (pp. 371\u2013373)
\nChapter 39, \u201cDrugs for Hypertension\u201d (pp. 375\u2013388)
\nChapter 40, \u201cDrugs for Heart Failure\u201d (pp. 389\u2013402)
\nChapter 41, \u201cAntidysrhythmic Drugs\u201d (pp. 403\u2013418)
\nChapter 42, \u201cProphylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels\u201d (pp. 419\u2013439)
\nChapter 43, \u201cDrugs for Angina Pectoris\u201d (pp. 441\u2013450)
\nChapter 44, \u201cAnticoagulant and Antiplatelet Drugs\u201d (pp. 451\u2013472)
\nRequired Media
\nCardiovascular Disorders<\/p>\n
Meet Dr. Norbert Myslinski as he discusses ACE inhibitors, angiotensin inhibitors, beta-blockers, calcium channel blockers, and diuretics as different categories of hypertension drugs. What potential drugs might be best recommended for patients suffering from hypertension? (8m) NURS 6521: Advanced Pharmacology Resource List<\/p>\n
Accessible player \u2013Downloads\u2013Download Video w\/CCDownload AudioDownload Transcript Cardiovascular Disorders<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 3
\nRequired Readings
\nRosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 60, \u201cDrugs for Asthma and Chronic Obstructive Pulmonary Disease\u201d (pp. 673\u2013693)
\nChapter 61, \u201cDrugs for Allergic Rhinitis, Cough, and Colds\u201d (pp. 695\u2013702)
\nDocument: Help write my thesis – APA Presentation Template<\/p>\n
National Heart Lung and Blood Institute. (2007). Expert panel report 3 (EPR3): Guidelines for the diagnosis and management of asthma. Retrieved from http:\/\/www.nhlbi.nih.gov\/guidelines\/asthma\/asthgdln.htm<\/p>\n
This web resource presents guidelines for diagnosing and managing asthma and outlines treatment recommendations for specific age groups. NURS 6521: Advanced Pharmacology Resource List<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 4
\nRequired Readings
\nRosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 62, \u201cDrugs for Peptic Ulcer Disease\u201d (pp. 703\u2013714)
\nChapter 63, \u201cLaxatives\u201d (pp. 715\u2013722)
\nChapter 64, \u201cOther Gastrointestinal Drugs\u201d (pp. 723\u2013735)
\nChapter 78, \u201cAntiviral Agents I: Drugs for Non-HIV Viral Infections\u201d (pp. 867\u2013886)
\nChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., . . . Sanya, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328\u2013357. Retrieved from https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.29367<\/p>\n
This article details the diagnosis and management of nonalcoholic fatty liver disease. Review this article to gain an understanding of the underlying pathophysiology as well as the suggested pharmacotherapeutics that might be recommended to treat this disorder.<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 5
\nRequired Readings
\nRosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 46, \u201cDrugs for Diabetes Mellitus\u201d (pp. 485\u2013509)
\nChapter 47, \u201cDrugs for Thyroid Disorders\u201d (pp. 511\u2013520)
\nAmerican Diabetes Association. (2018). Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes\u20142018. Diabetes Care, 41(Supplement 1), S73\u2013S85. Retrieved from http:\/\/care.diabetesjournals.org\/content\/41\/supplement_1\/s73.full-text.pdf NURS 6521: Advanced Pharmacology Resource List<\/p>\n
This article provides guidance on pharmacologic approaches to glycemic treatment as it pertains to treating patients with diabetes. Reflect on the content of this article as you continue to examine potential drug treatments for patients with diabetes.<\/p>\n
Document: Mid-Term Summary & Study Guide (PDF)<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 6
\nRequired Readings
\nRosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 10, \u201cBasic Principles of Neuropharmacology\u201d (pp. 73\u201377)
\nChapter 11, \u201cPhysiology of the Peripheral Nervous System\u201d (pp. 79\u201390)
\nChapter 12, \u201cMuscarinic Agonists and Antagonists\u201d (pp. 91\u2013107)
\nChapter 13, \u201cAdrenergic Agonists\u201d (pp. 109\u2013119)
\nChapter 14, \u201cAdrenergic Antagonists\u201d (pp. 121\u2013132)
\nChapter 15, \u201cIndirect-Acting Antiadrenergic Agents\u201d (pp. 133\u2013137)
\nChapter 16, \u201cIntroduction to Nervous System Pharmacology\u201d (pp. 139\u2013141)
\nChapter 17, \u201cDrugs for Parkinson Disease\u201d (pp. 143\u2013158)
\nChapter 18, \u201cDrugs for Alzheimer Disease\u201d (pp. 159\u2013166)
\nChapter 19, \u201cDrugs for Epilepsy\u201d (pp. 167\u2013189)
\nChapter 20, \u201cDrugs for Muscle Spasm and Spasticity\u201d (pp. 191\u2013201)
\nChapter 57, \u201cDrug Therapy of Rheumatoid Arthritis\u201d (pp. 629\u2013641)
\nChapter 58, \u201cDrug Therapy of Gout\u201d (pp. 643\u2013651)
\nChapter 59, \u201cDrugs Affecting Calcium Levels and Bone Mineralization\u201d (pp. 653\u2013672)
\nAmerican Academy of Family Physicians. (2019). Dementia. Retrieved from http:\/\/www.aafp.org\/afp\/topicModules\/viewTopicModule.htm?topicModuleId=5<\/p>\n
This website provides information relating to the diagnosis, treatment, and patient education of dementia. It also presents information on complications and special cases of dementia.<\/p>\n
Document: Mid-Term Summary & Study Guide (PDF)<\/p>\n
Required Media
\nLaureate Education (Producer). (2019b). Alzheimer\u2019s disease [Interactive media file]. Baltimore, MD: Author.<\/p>\n
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat Alzheimer\u2019s disease. NURS 6521: Advanced Pharmacology Resource List<\/p>\n
Laureate Education (Producer). (2019e). Complex regional pain disorder [Interactive media file]. Baltimore, MD: Author.<\/p>\n
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat complex regional pain disorders.<\/p>\n
Disorders of The Nervous System<\/p>\n
Reflect on the comprehensive review of disorders of the nervous system and think about how you might recommend or prescribe pharmacotherapeutics to treat these disorders. (15m)<\/p>\n
Accessible player \u2013Downloads\u2013Download Video w\/CCDownload AudioDownload Transcript Disorders of the Nervous System<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 8
\nRequired Readings
\nRosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 24, \u201cAntipsychotic Agents and Their Use in Schizophrenia\u201d (pp. 231\u2013246)
\nChapter 25, \u201cAntidepressants\u201d (pp. 247\u2013265)
\nChapter 26, \u201cDrugs for Bipolar Disorder\u201d (pp. 267\u2013274)
\nChapter 27, \u201cSedative-Hypnotic Drugs\u201d (pp. 275\u2013285)
\nChapter 28, \u201cManagement of Anxiety Disorders\u201d (pp. 287\u2013292)
\nChapter 29, \u201cCentral Nervous System Stimulants and Attention-Deficit\/Hyperactivity Disorder\u201d (pp. 293\u2013299)
\nRequired Media
\nLaureate Education (Producer). (2019a). Adult geriatric depression [Interactive media file]. Baltimore, MD: Author. NURS 6521: Advanced Pharmacology Resource List<\/p>\n
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat adult geriatric depression.<\/p>\n
Laureate Education (Producer). (2019c). Attention deficit hyperactivity disorder [Interactive media file]. Baltimore, MD: Author.<\/p>\n
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat attention deficit hyperactivity disorder.<\/p>\n
Laureate Education (Producer). (2019d). Bipolar therapy [Interactive media file]. Baltimore, MD: Author.<\/p>\n
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics for bipolar therapy.<\/p>\n
Laureate Education (Producer). (2019g). Generalized anxiety disorder [Interactive media file]. Baltimore, MD: Author.<\/p>\n
In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat generalized anxiety disorder.<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 9
\nRequired Readings
\nRosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advacned practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 48, \u201cEstrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications\u201d (pp. 521\u2013533) NURS 6521: Advanced Pharmacology Resource List
\nChapter 49, \u201cBirth Control\u201d (pp. 535\u2013547)
\nChapter 50, \u201cAndrogens\u201d (pp. 549\u2013556)
\nChapter 51, \u201cDrugs for Erectile Dysfunction and Benign Prostatic Hyperplasia\u201d (pp. 557\u2013569)
\nLunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015). Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male, 18(1), 5\u201315. doi:10.3109\/13685538.2015.1004049<\/p>\n
Note: Retrieved from the Walden Library databases.<\/p>\n
This article presents recommendations on the diagnosis, treatment, and monitoring of hypogonadism in men. Reflect on the concepts presented and consider how this might impact your role as an advanced practice nurse in treating men\u2019s health disorders.<\/p>\n
Roberts, H., & Hickey, M. (2016). Managing the menopause: An update. Maturitas, 86(2016), 53\u201358. https:\/\/doi.org\/10.1016\/j.maturitas.2016.01.007<\/p>\n
Note: Retrieved from the Walden Library databases.<\/p>\n
This article provides an update on treatments on Vasomotor symptoms (VMS), genito-urinary syndrome of menopause (GSM), sleep disturbance, sexual dysfunction, and mood disturbance that are common during the menopause transition.<\/p>\n
Agency for Healthcare Research and Quality. (2014). Guide to clinical preventive services, 2014: Section 2. Recommendations for adults. Retrieved from http:\/\/www.ahrq.gov\/professionals\/clinicians-providers\/guidelines-recommendations\/guide\/section2.html<\/p>\n
This website lists various preventive services available for men and women and provides information about available screenings, tests, preventive medication, and counseling.<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 10
\nRequired Readings
\nRosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 68, \u201cBasic Principles of Antimicrobial Therapy\u201d (pp. 769\u2013781)
\nChapter 69, \u201cDrugs That Weaken the Bacterial Cell Wall I: Penicillins\u201d (pp. 783\u2013790)
\nChapter 73, \u201cSulfonamides and Trimethoprim\u201d (pp. 619\u2013826)
\nChapter 74, \u201cDrug Therapy of Urinary Tract Infections\u201d (pp. 827\u2013831)
\nChapter 75, \u201cAntimycobacterial Agents\u201d (pp. 833\u2013847)
\nChapter 76, \u201cMiscellaneous Antibacterial Drugs\u201d (pp. 849\u2013853)
\nChapter 77, \u201cAntifungal Agents\u201d (pp. 855\u2013866)
\nChapter 78, \u201cAntiviral Agents I: Drugs for Non-HIV Viral Infections\u201d (pp. 867\u2013886)
\nChapter 80, \u201cDrug Therapy of Sexually Transmitted Diseases\u201d (pp. 905\u2013911)
\nMontaner, J. S. G., Lima, V. D., Harrigan, P. R., Louren\u00e7o, L., Yip, B., Nosyk, B., \u2026 Kendall, P. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: The \u201cHIV Treatment as Prevention\u201d experience in a Canadian setting. PLoS ONE, 9(2), e87872. Retrieved from https:\/\/doi.org\/10.1371\/journal.pone.0087872<\/p>\n
This study examines HAART therapy and its sustainability and profound population-level decrease in morbidity, mortality, and HIV transmission.<\/p>\n
Document: Final Exam Study Guide (PDF)<\/p>\n
Required Media
\nPathopharmacology: Pharmacology and Immunological Disorders: Improvements in Medications and Drug Administration<\/p>\n
Nurse Manager, Bette Nunn discusses how technology has improved the practice of administering drugs and created new and improved drug therapies. Why is technology as well as a patient\u2019s knowledge of their own drug history important for nursing practice? (8m)<\/p>\n
Accessible player \u2013Downloads\u2013Download Video w\/CCDownload AudioDownload Transcript Pharmacology and the Immunological Disorders<\/p>\n
NURS 6521: Advanced Pharmacology Assignment Resources \u2013 Week 11
\nRequired Readings
\nRosenthal, L. D., & Burchum, J. R. (2018). Lehne\u2019s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.<\/p>\n
Chapter 8, \u201cDrug Therapy in Pediatric Patients\u201d (pp. 65\u201467)
\nCorny, J., Lebel, D., Bailey, B., & Bussieres, J. (2015). Unlicensed and off-label drug use in children before and after pediatric governmental initiatives. The Journal of Pediatric Pharmacology and Therapeutics, 20(4), 316\u2013328.<\/p>\n
Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4557722\/<\/p>\n
This article highlights pediatric governmental initiatives to prevent unlicensed and off-label drug use in children. Review these initiatives and guidelines and how they might impact your practice as an advanced practice nurse.<\/p>\n
Panther, S. G., Knotts, A. M., Odom-Maryon, T., Daratha, K., Woo, T., & Klein, T. A. (2017). Off-label prescribing trends for ADHD medications in very young children. The Journal of Pediatric Pharmacology and Therapeutics, 22(6), 423\u2013429. doi:10.5863\/1551-6776-22.6.423 NURS 6521: Advanced Pharmacology Resource List<\/p>\n
Note: You will access this article from the Walden Library databases.<\/p>\n
This study examines the frequency of off-label prescribing to children and explores factors that impact off-label prescribing. This study also examines off-label prescribing to children with ADHD.<\/p>\n
Document: Final Exam Study Guide (PDF)<\/p>\n
Required Media
\nLaureate Education (Producer). (2019i). Therapy for pediatric clients with mood disorders [Interactive media file]. Baltimore, MD: Author.<\/p>\n","protected":false},"excerpt":{"rendered":"
NURS 6521: Advanced Pharmacology Assignment Resources Syllabus Resource List This page contains all of the resources for this course. NURS 6521: Advanced Pharmacology Assignment Resources\u2026<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1738,2474,2482,1563,2516,2499],"tags":[2501,2518,2477,2519,2520],"class_list":["post-9732","post","type-post","status-publish","format-standard","hentry","category-help-me-with-social-psychology-assignment","category-psyc-essays","category-psyc-paper-writing-service","category-psychology-case-study-examples","category-sociology-essays","category-write-my-psychology-papers","tag-psy-papers","tag-psych-research-paper-sample","tag-psychology-assignment","tag-psychology-dissertation-writing","tag-psychology-research-paper"],"_links":{"self":[{"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/posts\/9732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/comments?post=9732"}],"version-history":[{"count":0,"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/posts\/9732\/revisions"}],"wp:attachment":[{"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/media?parent=9732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/categories?post=9732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/tags?post=9732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}